BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11184669)

  • 1. Therapeutic substitution of cimetidine for nizatidine was not associated with an increase in healthcare utilization.
    Good CB; Fultz SL; Trilli L; Etchason J
    Am J Manag Care; 2000 Oct; 6(10):1141-6. PubMed ID: 11184669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A practice-based approach for converting from proton pump inhibitors to less costly therapy.
    Lucas LM; Gerrity MS; Anderson T
    Eff Clin Pract; 2001; 4(6):263-70. PubMed ID: 11769299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of patient satisfaction with a formulary switch from omeprazole to lansoprazole in gastroesophageal reflux disease maintenance therapy.
    Condra LJ; Morreale AP; Stolley SN; Marcus D
    Am J Manag Care; 1999 May; 5(5):631-8. PubMed ID: 10537869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic-interchange program for oral histamine H2-receptor antagonists.
    Chase SL; Peterson AM; Wordell CJ
    Am J Health Syst Pharm; 1998 Jul; 55(13):1382-6. PubMed ID: 9659966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rational selection of H2-receptor antagonists for the hospital formulary. Roundtable discussion.
    Keeffe EB; Harper JM; LeMay A; Sherrin TP; Siepler JK
    Hosp Formul; 1991 Nov; 26 Suppl D():13-9. PubMed ID: 10136560
    [No Abstract]   [Full Text] [Related]  

  • 6. Nizatidine for the treatment of pediatric gastroesophageal reflux symptoms: an open-label, multiple-dose, randomized, multicenter clinical trial in 210 children.
    Orenstein SR; Gremse DA; Pantaleon CD; Kling DF; Rotenberg KS
    Clin Ther; 2005 Apr; 27(4):472-83. PubMed ID: 15922820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective analysis of formulary restriction demonstrates significant cost savings.
    Wetmore RW; Jennings RH
    Hosp Formul; 1991 Nov; 26 Suppl D():30-2. PubMed ID: 10136564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of nizatidine with the three other histamine receptor antagonists for duodenal ulcer therapy.
    Lima M; Holdcroft C
    Nurse Pract; 1989 Feb; 14(2):41-2. PubMed ID: 2564655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lansoprazole overutilization: methods for step-down therapy.
    Pohland CJ; Scavnicky SA; Lasky SS; Good CB
    Am J Manag Care; 2003 May; 9(5):353-8. PubMed ID: 12744297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization and expenditures of veterans obtaining primary care in community clinics and VA medical centers: an observational cohort study.
    Maciejewski ML; Perkins M; Li YF; Chapko M; Fortney JC; Liu CF
    BMC Health Serv Res; 2007 Apr; 7():56. PubMed ID: 17442115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilization and costs for children who have special health care needs and are enrolled in a hospital-based comprehensive primary care clinic.
    Berman S; Rannie M; Moore L; Elias E; Dryer LJ; Jones MD
    Pediatrics; 2005 Jun; 115(6):e637-42. PubMed ID: 15930189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Criteria-based DUE aids in selection of preferred agent.
    Drea EJ
    Hosp Formul; 1991 Nov; 26 Suppl D():25-7. PubMed ID: 10136562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiulcer therapy: an exercise in formulary management.
    Foulke GE; Siepler J
    J Clin Gastroenterol; 1990; 12 Suppl 2():S64-8. PubMed ID: 1978846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing outpatient costs of nonsteroidal antiinflammatory drugs at a Department of Veterans Affairs teaching hospital.
    Drexler PG; Lambdin CS
    J Pharm Technol; 1993; 9(1):10-3. PubMed ID: 10123760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Healthcare use by veterans treated for diabetes mellitus in the Veterans Affairs medical care system.
    Ashton CM; Septimus J; Petersen NJ; Souchek J; Menke TJ; Collins TC; Wray NP
    Am J Manag Care; 2003 Feb; 9(2):145-50. PubMed ID: 12597602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Budget impact of tegaserod on a managed care organization formulary.
    Bloom MA; Barghout V; Kahler KH; Bentkover J; Kurth H; Gralnek IM; Spiegel BM
    Am J Manag Care; 2005 Apr; 11(1 Suppl):S27-34. PubMed ID: 15926761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Healthcare utilization and costs of patients with rosacea in an insured population.
    Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
    J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-related emergency department visits in an elderly veteran population.
    Yee JL; Hasson NK; Schreiber DH
    Ann Pharmacother; 2005 Dec; 39(12):1990-5. PubMed ID: 16288080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical importance of antagonists of histamine H2 receptors in gastroenterology].
    Carella G
    Clin Ter; 1984 Mar; 108(6):525-9. PubMed ID: 6144411
    [No Abstract]   [Full Text] [Related]  

  • 20. Change in prescribing patterns of intravenous histamine2-receptor antagonists results in significant cost savings without adversely affecting patient care.
    Fudge KA; Moore KA; Schneider DN; Sherrin TP; Wellman GS
    Ann Pharmacother; 1993 Feb; 27(2):232-7. PubMed ID: 8094986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.